PRESS RELEASE published on 05/11/2023 at 14:30, 3 years 6 months ago Canalevia-CA1, Jaguar Animal Health’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs, Now Available from Chewy
PRESS RELEASE published on 05/10/2023 at 14:30, 3 years 6 months ago Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug
PRESS RELEASE published on 05/09/2023 at 14:30, 3 years 6 months ago Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 05/08/2023 at 14:30, 3 years 6 months ago Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
PRESS RELEASE published on 05/05/2023 at 22:15, 3 years 6 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 05/01/2023 at 14:30, 3 years 6 months ago Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi
PRESS RELEASE published on 04/27/2023 at 14:30, 3 years 6 months ago U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care
PRESS RELEASE published on 04/11/2023 at 14:30, 3 years 7 months ago Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 04/06/2023 at 14:30, 3 years 7 months ago Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
PRESS RELEASE published on 03/30/2023 at 14:30, 3 years 7 months ago Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Published on 11/11/2026 at 16:30, 38 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 2 hours 43 minutes ago Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 3 hours 8 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 3 hours 8 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 13:15, 3 hours 53 minutes ago Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
Published on 11/11/2026 at 16:51, 16 minutes ago Research Dynamics - Report on CPHN: Investor Day Update
Published on 11/11/2026 at 16:45, 23 minutes ago EQS-Adhoc: Ad-hoc: Gerhard Hanke appointed CEO of Wienerberger AG
Published on 11/11/2026 at 16:36, 32 minutes ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy
Published on 11/11/2026 at 16:30, 38 minutes ago TCMA Advances "Reimagining Carbon" to Turn CO₂ into New Economic Opportunities
Published on 11/10/2026 at 18:00, 23 hours 8 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 23 hours 23 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 23 hours 33 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 23 hours 36 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
